These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32685556)

  • 1. Attenuation of Diabetic Nephropathy in Diabetic Mice by Fasudil through Regulation of Macrophage Polarization.
    Xie F; Lei J; Ran M; Li Y; Deng L; Feng J; Zhong Y; Li J
    J Diabetes Res; 2020; 2020():4126913. PubMed ID: 32685556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
    Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
    Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
    Liu C; Li Y; Yu J; Feng L; Hou S; Liu Y; Guo M; Xie Y; Meng J; Zhang H; Xiao B; Ma C
    PLoS One; 2013; 8(2):e54841. PubMed ID: 23418431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
    Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
    Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
    Hofni A; Shehata Messiha BA; Mangoura SA
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.
    Xie Y; Song T; Huo M; Zhang Y; Zhang YY; Ma ZH; Wang N; Zhang JP; Chu L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5665-5677. PubMed ID: 30229844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats.
    Kikuchi Y; Yamada M; Imakiire T; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Oda T; Suzuki S; Miura S
    J Endocrinol; 2007 Mar; 192(3):595-603. PubMed ID: 17332527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.
    Chen C; Li YH; Zhang Q; Yu JZ; Zhao YF; Ma CG; Xiao BG
    Acta Pharmacol Sin; 2014 Nov; 35(11):1428-38. PubMed ID: 25263338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho kinase inhibitor fasudil regulates microglia polarization and function.
    Zhang H; Li Y; Yu J; Guo M; Meng J; Liu C; Xie Y; Feng L; Xiao B; Ma C
    Neuroimmunomodulation; 2013; 20(6):313-22. PubMed ID: 23941863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.
    Komers R; Oyama TT; Beard DR; Tikellis C; Xu B; Lotspeich DF; Anderson S
    Kidney Int; 2011 Feb; 79(4):432-42. PubMed ID: 20962741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
    Mohammad G; AlSharif HM; Siddiquei MM; Ahmad A; Alam K; Abu El-Asrar AM
    Ann Clin Lab Sci; 2018 Mar; 48(2):137-145. PubMed ID: 29678838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rho-kinase inhibitor fasudil restores normal motor nerve conduction velocity in diabetic rats by assuring the proper localization of adhesion-related molecules in myelinating Schwann cells.
    Kanazawa Y; Takahashi-Fujigasaki J; Ishizawa S; Takabayashi N; Ishibashi K; Matoba K; Kawanami D; Yokota T; Tajima N; Utsunomiya K
    Exp Neurol; 2013 Sep; 247():438-46. PubMed ID: 23337773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α.
    Matoba K; Kawanami D; Okada R; Tsukamoto M; Kinoshita J; Ito T; Ishizawa S; Kanazawa Y; Yokota T; Murai N; Matsufuji S; Takahashi-Fujigasaki J; Utsunomiya K
    Kidney Int; 2013 Sep; 84(3):545-54. PubMed ID: 23615507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy.
    Matoba K; Kawanami D; Nagai Y; Takeda Y; Akamine T; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperoside Suppresses Renal Inflammation by Regulating Macrophage Polarization in Mice With Type 2 Diabetes Mellitus.
    Liu J; Zhang Y; Sheng H; Liang C; Liu H; Moran Guerrero JA; Lu Z; Mao W; Dai Z; Liu X; Zhang L
    Front Immunol; 2021; 12():733808. PubMed ID: 34925317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.
    Kanda T; Wakino S; Hayashi K; Homma K; Ozawa Y; Saruta T
    Kidney Int; 2003 Dec; 64(6):2009-19. PubMed ID: 14633123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho kinase inhibition: a new approach for treating diabetic nephropathy?
    Bach LA
    Diabetes; 2008 Mar; 57(3):532-3. PubMed ID: 18305148
    [No Abstract]   [Full Text] [Related]  

  • 20. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes.
    Zhou H; Fang C; Zhang L; Deng Y; Wang M; Meng F
    Chin Med J (Engl); 2014; 127(2):225-31. PubMed ID: 24438608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.